Community-acquired pneumonia against a background of chronic heart failure: diagnosis and treatment
Community-acquired pneumonia is one of the most common infectious diseases in developed countries. Chronic heart failure is an independent risk factor for unfavorable course and prognosis of community-acquired pneumonia. Objective challenges of clinical, radiological, laboratory and microbiological...
Main Authors: | A. A. Bobylev, S. A. Rachina, R. S. Kozlov, N. N. Dekhnich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2014-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/769 |
Similar Items
-
Moxifloxacin: safety profile
by: A. I. Sinopalnikov
Published: (2013-12-01) -
Challenges and options in the etiotropic treatment of bacterial rhinosinusitis
by: G. N. Nikiforova, et al.
Published: (2015-12-01) -
Respiratory fluoroquinolones in outpatient clinical practice
by: R. S. Kozlov, et al.
Published: (2015-12-01) -
Fluoroquinolones in ambulatory surgical practice: whom, when, how?
by: A. V. Golub, et al.
Published: (2016-06-01) -
Moxifloxacin in the treatment of community-acquired pneumonia in adults: what's new?
by: A. I. Sinopalnikov
Published: (2014-12-01)